Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous infusion versus intermittent bolus flucloxacillin for uncomplicated cellulitis
ACTRN12610000682044Phase 4Not yet recruiting
- Sponsor
- Royal Brisbane and Women's Hospital
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of flucloxacillin in cellulitis (2 arms), sponsored by Royal Brisbane and Women's Hospital. Primary endpoints: Nursing time in preparing and administering drug and Patient and nurse satisfaction. Planned start Oct 2010; status: not yet recruiting.
02
Drugs
flucloxacillin
03
Conditions
cellulitis
Beyond the preview
Go deeper on ACTRN12610000682044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000682044.